Big pharma accused of 'free-riding on nature' as Cali Fund attracts just $7,000

Summary

The Cali Fund, set up to raise $1bn (£750m) a year for biodiversity by asking companies that profit from nature's genetics to contribute to conservation in low-income countries, remains near empty more than 18 months after its launch and far below its target. Big pharmaceutical companies have been accused of "free-riding on nature" after the fund, which invites businesses to put some of their profits back into conservation, was left virtually empty.

Timeline

1. The Guardian

   22 Oct 2026, 09:00 UTCSource ↗

   The Guardian reports that big pharmaceutical companies have been accused of "free-riding on nature" after the Cali Fund, which aims to raise $1bn a year from drug companies for biodiversity, attracted just $7,000 and remains far below target more than 18 months after its launch.